Justin Bachmann, MD, MPH, FACC, instructor of Medicine and Health Policy at Vanderbilt University Medical Center, discusses how cardiologists incorporate value-based care into their procedures.
Justin Bachmann, MD, MPH, FACC, instructor of Medicine and Health Policy at Vanderbilt University Medical Center, discusses how cardiologists incorporate value-based care into their procedures.
Transcript
How is cardiology handling the transition to value-based care and what models are a good fit with cardiology care?
I say we have a little bit of a head start. So cardiology has been involved in value-based care for a while now. We started in the '90s with the development with our registries, specifically the National Cardiovascular Data Registry, which was developed by the American College of Cardiology.
So we have registries that focus on specific procedures, for example PCI or percutaneous coronary intervention, this is soften normally for to as a stent. Also things such as implantable cardioverter defibrillators (ICDs). So these registries collect granular information on patients who are going through these procedures. That really prepared us for that transition so it continued to evolve as bundled payments and episodes of care continue to evolve. I think cardiology will be prepared for that.
A number of the proposed bundled payment models, for example focused on acute myocardio infarction or bypass and those, are a little bit in flux in present, but as these models continue to change and evolve and they’ll continue to do so over the coming years. I think cardiologists will engage with those.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More